How many days should Ofloxacin and ornidazole for smelly diarrhoea

Reading File
Searching the Web

ofloxacin ornidazole duration days infective diarrhea treatment

Finding Sources
Finding Sources
Finding Sources
The textbook library doesn't have a specific entry for this combination, but the regulatory drug information (NAFDAC, Rwanda FDA product inserts) and clinical practice sources are clear. Here is the full answer:

Ofloxacin + Ornidazole for Smelly (Foul-smelling) Diarrhea

Duration: 5 days (standard); up to 10 days for severe or complicated infections

Typical Dosing (Adults)

ParameterDetails
DoseOfloxacin 200 mg + Ornidazole 500 mg (fixed-dose combination tablet)
FrequencyTwice daily (every 12 hours)
Duration5 days for uncomplicated infective diarrhea; up to 10 days for severe infections
RouteOral, with or without food

Why This Combination?

Foul/smelly diarrhea typically suggests:
  • Anaerobic bacteria or protozoal infection (Giardia lamblia, Entamoeba histolytica)
  • Ofloxacin (fluoroquinolone) covers gram-negative aerobic bacteria (E. coli, Salmonella, Shigella, Campylobacter)
  • Ornidazole (nitroimidazole) covers anaerobes and protozoa (Giardia, Entamoeba)

Practical Points

  • 5 days is the standard course for most community-acquired infective diarrhea
  • If symptoms resolve earlier, still complete the full 5-day course
  • If no improvement by day 3, re-evaluate - consider stool culture, resistant organism, or alternative diagnosis
  • Do not use in children under 18 (fluoroquinolone restriction), epileptics, or patients with known quinolone allergy
  • Avoid in pregnancy (both agents carry risk)
  • Adequate hydration (ORS) is equally important alongside antibiotics

When to extend to 10 days

  • Invasive amebiasis (amebic dysentery)
  • Immunocompromised patients
  • Severe or hospital-acquired infection
Source: Official product inserts - Rwanda FDA/Oflozole PIL | NAFDAC/Ornilox SMPC
Note: These are general guidelines. Always follow local prescribing guidelines and the treating physician's judgment, especially in pediatric patients, pregnant women, or those with renal impairment.

Community acquired infective diarrhoea treatment chart

Finding Sources
Searching the Web

community acquired infective diarrhea treatment guidelines 2024 antibiotic chart

Finding Sources
Reading Web Page

community acquired infectious diarrhea antibiotic treatment chart organism drug dose duration

Finding Sources
Reading File
I now have enough from authoritative sources (Goldman-Cecil Medicine, PMC guideline, Catholic Health 2024 guide, IDSA guidelines) to build a comprehensive treatment chart. Let me compile this now.

Community-Acquired Infective Diarrhoea - Treatment Chart

Step 1: Initial Assessment

FeatureAction
Watery, mild, no fever, <3 daysSupportive care only - ORS, no antibiotics
Fever + bloody stool (dysentery)Stool culture + empiric antibiotics
Foul-smelling, frothy, no bloodSuspect Giardia/anaerobes - ornidazole
Traveller's diarrheaAzithromycin ± bismuth subsalicylate
Rice-water stool, profuseSuspect cholera - urgent rehydration + doxycycline
Persistent >7 daysStool microscopy for ova & cysts
Immunocompromised / hospitalizedID consultation, broader workup

Step 2: Empiric Antibiotic Treatment by Syndrome

Organism / SyndromeFirst-Line DrugDose & FrequencyDurationNotes
Empiric (unspecified bacterial)Ciprofloxacin500 mg PO twice daily3 daysResistance rising; use only if needed
Levofloxacin500 mg PO once daily3 daysAlternative fluoroquinolone
Azithromycin500 mg PO once daily3 daysPreferred if fluoroquinolone resistance suspected
Azithromycin1000 mg POSingle doseTraveller's diarrhea (moderate-severe)
Rifaximin200 mg PO three times daily3 daysNon-invasive E. coli, traveller's diarrhea
Mixed bacterial + protozoalOfloxacin 200 mg + Ornidazole 500 mg1 tablet twice daily5 days (up to 10 days if severe)Covers gram-negatives + anaerobes + protozoa
Shigella spp.Azithromycin500 mg PO once daily3 daysFirst-line due to fluoroquinolone resistance
Ciprofloxacin500 mg PO twice daily3 daysIf susceptible
Salmonella (non-typhoidal)Ciprofloxacin500 mg PO once daily5 daysOnly in high-risk patients; avoid in mild disease
Ceftriaxone1 g IV once daily5 daysSevere or bacteraemic cases
Salmonella Typhi / ParatyphiCiprofloxacin500 mg PO once daily5-7 daysID consultation if bacteraemic
Ceftriaxone1 g IV once daily5-7 daysFor severe/hospitalized cases
Campylobacter spp.Azithromycin500 mg PO once daily3 daysFluoroquinolone resistance common
Giardia lambliaMetronidazole400 mg PO three times daily5-7 daysClassic anti-protozoal choice
Ornidazole1.5 g PO once dailySingle doseConvenient single-dose option
Tinidazole2 g POSingle doseHighly effective
Entamoeba histolytica (amoebiasis)Metronidazole800 mg PO three times daily5-10 daysThen follow with luminal agent
Ornidazole500 mg twice daily5-10 daysPart of combination therapy
+ Diloxanide furoate500 mg three times daily10 daysTo eliminate luminal cysts
Vibrio choleraeDoxycycline100 mg PO/IV twice daily3-5 daysVolume repletion is primary treatment
Azithromycin1 g POSingle doseAlternative, especially in pregnancy
Yersinia spp.Levofloxacin500 mg PO once daily3 daysOnly for severe illness; most cases self-limiting
Vibrio parahemolyticusSupportive care only-5-7 daysAntibiotics do not shorten illness
C. difficile (CDI)Vancomycin (oral)125 mg PO four times daily10 daysDo NOT use metronidazole as first-line
Fidaxomicin200 mg PO twice daily10 daysPreferred to reduce recurrence

Step 3: Supportive Care (All Cases)

InterventionDetails
ORS (Oral Rehydration Solution)WHO ORS: 200-400 mL after each loose stool
Zinc20 mg/day for 10-14 days (paediatric use, reduces duration)
ProbioticsLactobacillus GG or Saccharomyces boulardii - reduces duration by ~1 day
Loperamide4 mg initially then 2 mg after each loose stool (max 16 mg/day) - for watery, non-dysenteric only; avoid in bloody diarrhea
Bismuth subsalicylate30 mL every 4-6 hours PRN - mild traveller's diarrhea
DietBRAT diet (banana, rice, applesauce, toast); avoid dairy, caffeine, fatty foods

When NOT to give antibiotics

  • Watery diarrhea, no fever, no blood, mild illness
  • Viral gastroenteritis (norovirus, rotavirus)
  • Vibrio parahemolyticus - self-limiting
  • Non-typhoidal Salmonella in healthy adults (prolongs carrier state)
  • E. coli O157:H7 (STEC/HUS risk - antibiotics may worsen outcome)

Sources: Goldman-Cecil Medicine (26th ed.) | Guideline for Antibiotic Use in Acute Gastroenteritis, PMC6609748 | Catholic Health 2024 Antimicrobial Guide | IDSA 2017 Infectious Diarrhea Guidelines
Disclaimer: This chart is for educational/reference purposes. Always apply local antibiogram data, patient-specific factors (allergy, pregnancy, renal function), and clinical judgment when prescribing.
This is a shared conversation. Sign in to Orris to start your own chat.